Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?

Creative Commons License

IPEKCI T., YUKSEL M., Ucar M., Tunckiran A., KOZACIOGLU Z., Akman R. Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.16, sa.4, ss.119-122, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/uob.900
  • Dergi Adı: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.119-122
  • Anahtar Kelimeler: Inflammation, neutrophil-to-lymphocyte ratio, prostate cancer, INFLAMMATION
  • Akdeniz Üniversitesi Adresli: Hayır

Özet

Objective: In spite of all efforts, prostate cancer is still the 2nd highest cause of cancer-related deaths in men. For this reason new developments are needed in diagnosis, treatment and follow-up of prostate cancer. Neutrophil/lymphocyte (N/L) ratio is a cheap and effective parameter used for research into many solid tumors; but there are not enough studies on the reliability of this parameter in prostate cancer. In this study we researched the efficacy of N/L ratio in localized prostate cancer.